My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

15.41 +0.19 (+1.25%)

Streaming Delayed Price Updated: 2:52 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Tuesday Markets Review ↗

November 30, 2021

The oil price did not fall as expected over the White House release of 50 mn bbls of oil.

Via Talk Markets

61 Biggest Movers From Yesterday ↗

November 23, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises 200 Points; Niu Technologies Shares Slide ↗

November 22, 2021

Toward the end of trading Monday, the Dow traded up 0.59% to 35,811.07 while the NASDAQ fell 0.43% to 15,989.15. The S&P also rose, gaining 0.43% to 4,718.05. The U.S. has the...

Via Benzinga

Topics Stocks

Is An Aurinia Pharmaceuticals Buyout Coming? Why This Has Investors Doubting It ↗

November 22, 2021

Aurinia tanked Monday as an SEC filing had investors questioning buyout rumors.

Via Investor's Business Daily

Topics Regulatory Compliance

Financial Stocks: WFC, MS, C, BAC, JPM and GS Gain on Powell Fed Chairman’s Second Term ↗

November 22, 2021

Financial stocks are doing well on Monday thanks to an update from the U.S. Government concerning the next Federal Reserve chairman.

Via InvestorPlace

Topics Economy

AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today ↗

November 22, 2021

Aurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday.

Via InvestorPlace

Topics Regulatory Compliance

Mid-Day Market Update: Gold Down 2%; iSpecimen Shares Spike Higher ↗

November 22, 2021

Midway through trading Monday, the Dow traded up 0.65% to 35,832.70 while the NASDAQ rose 0.67% to 16,164.51. The S&P also rose, gaining 0.87% to 4,738.91. The U.S. has the...

Via Benzinga

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session ↗

November 22, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...

Via Benzinga

Here's Why Aurinia Pharmaceuticals Is Falling Today ↗

November 22, 2021

The company's recently filed unlimited shelf registration statement is making shareholders queasy.

Via The Motley Fool

Mid-Morning Market Update: Markets Open Higher; Avaya Tops Q4 Views ↗

November 22, 2021

Following the market opening Monday, the Dow traded up 0.77% to 35,876.58 while the NASDAQ rose 0.91% to 16,203.01. The S&P also rose, gaining 0.91% to 4,740.94. The U.S. has...

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 22, 2021

Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday!

Via InvestorPlace

20 Stocks Moving in Monday's Pre-Market Session ↗

November 22, 2021

Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per...

Via Benzinga

Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday ↗

November 20, 2021

A $250 mixed shelf offering isn't sitting well with the biotech's shareholders.

Via The Motley Fool

Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference

November 10, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move? ↗

November 06, 2021

It could be.

Via The Motley Fool

What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals ↗

November 04, 2021

Over the past 3 months, 5 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:

Via Benzinga

Aurinia Pharmaceuticals Inc (AUPH) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

AUPH earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals ↗

November 03, 2021

The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on.

Via The Motley Fool

Aurinia Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2021

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the...

Via Benzinga

Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates

November 03, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis

November 01, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

No Negative Reaction ↗

October 28, 2021

Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 ↗

October 28, 2021

Upgrades For Boot Barn Holdings Inc (NYSE:

Via Benzinga

Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021

October 27, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021

October 26, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Cyber Currency ↗

October 26, 2021

Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.

Via Talk Markets

Aurinia Rockets — Again — On Rumored Bristol Marriage; Could Others Make A Pass? ↗

October 25, 2021

Aurinia stock hit another record Monday on Bristol's rumored takeover.

Via Investor's Business Daily

55 Biggest Movers From Friday ↗

October 25, 2021

Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World...

Via Benzinga

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today ↗

October 22, 2021

The biotech is reportedly in buyout talks with Bristol Myers Squibb.

Via The Motley Fool

Aurinia Pharma Stock Pops On Reports Of Looming Bristol Myers Takeover ↗

October 22, 2021

Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying before it was halted.

Via Investor's Business Daily

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition